ITGAE and neoplasm: Using mass cytometry to profile the evolution of the immune repertoire at an organism-wide level in response to immunotherapy, we found that in the initiation of anti-tumor immune responses, CD103+ DCs in the tumor microenvironment exhibit a strong increase in proliferation (Spitzer et al., 2017).